ABILIFY Now Available for Younger Patients with Bipolar Disorder
By MedHeadlines • Mar 3rd, 2008 • Category: Bipolar Disorder, Children's Health, Drugs, FDA, PreventionOtsuka Pharmaceutical Co., Ltd and Bristol-Myers Squibb Company have announced that a new drug for treatment of bipolar disorder in children and adolescents is now available. ABILIFY (aripiprazole) has been approved by the FDA for patients 10 to 17 years…
